Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

被引：135

作者：

Zhou, Jian

Sun, Huichuan

Wang, Zheng

Cong, Wenming

Zeng, Mengsu

Zhou, Weiping

Bie, Ping

Liu, Lianxin

Wen, Tianfu

Kuang, Ming

Han, Guohong

Yan, ZhiPing

Wang, Maoqiang

Liu, Ruibao

Lu, Ligong

Ren, Zhenggang

Zeng, ZhaoChong

Liang, Ping

Liang, Changhong

Chen, Min

Yan, Fuhua

Wang, Wenping

Hou, Jinlin

Ji, Yuan

Yun, Jingping

Bai, Xueli

Cai, Dingfang

Chen, Weixia

Chen, Yongjun

Cheng, Wenwu

Cheng, Shuqun

Dai, Chaoliu

Guo, Wenzhi

Guo, Yabing

Hua, Baojin

Huang, Xiaowu

Jia, Weidong

Li, Qiu

Li, Tao

Li, Xun

Li, Yaming

Li, Yexiong

Liang, Jun

Ling, Changquan

Liu, Tianshu

Liu, Xiufeng

Lu, Shichun

Lv, Guoyue

Mao, Yilei

Meng, Zhiqiang

机构：

[1] Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai

[2] Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai

[3] Department of Pathology, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai

[4] Department of Hepatobiliary and Spleenary Surgery, The Affiliated Shengjing Hospital, China Medical University, Shenyang

[5] Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai

[6] Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou

[7] The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai

[8] Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou

[9] Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing

[10] Graduate School, Beijing University of Chinese Medicine, Beijing

[11] Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin

[12] Department of Hepatic Surgery, Affiliated Provincial Hospital, Anhui Medical University, Hefei

[13] Department of Liver Surgery, West China Hospital of Sichuan University, Chengdu

[14] Department of Oncology, West China Hospital, Sichuan University, Chengdu

[15] Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou

[16] Department of General Surgery, Qilu Hospital, Shandong University, Jinan

[17] Department of Liver Diseases and Digestive Interventional Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an

[18] The First Hospital of Lanzhou University, Lanzhou

[19] Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai

[20] Department of Nuclear Medicine, The First Hospital of China Medical University, Shenyang

[21] Department of Interventional Radiology, Chinese PLA General Hospital, Beijing

[22] Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

[23] Department of Interventional Radiology, The Tumor Hospital of Harbin Medical University, Harbin

[24] Department of Oncology, Peking University International Hospital, Beijing

[25] Department of Interventional Oncology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou

[26] Changhai Hospital of Traditional Chinese Medicine, Second Military Medical University, Shanghai

[27] Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai

[28] Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai

[29] Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing

[30] Department of Medical Oncology, PLA Cancer Center, Nanjing Bayi Hospital, Nanjing

[31] Department of Radiology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou

[32] Institute and Hospital of Hepatobiliary Surgery of Chinese PLA, Chinese PLA Medical School, Chinese PLA General Hospital, Beijing

[33] Editorial Department of Chinese Journal of Digestive Surgery, Chongqing

[34] Department of General Surgery, The First Hospital of Jilin University, Jilin

[35] Department of Radiology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai

[36] Department of Liver Surgery, Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, Beijing

[37] Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai

[38] Department of Oncology, Shanghai Medical College, Fudan University, Shanghai

[39] Department of Infectious Diseases, State Key Laboratory of Organ Failure Research, Nanfang Hospital Southern Medical University, Guangzhou

[40] Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning

[41] Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai

[42] Department of Interventional Radiology the First Affiliated Hospital of Xinjiang Medical University, Urumqi

[43] Department of Pathology, Tumor Prevention and Treatment Center, Sun Yat-sen University, Guangzhou

[44] Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai

[45] Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine Zhejiang University, Hangzhou

[46] Department of Hepatobiliary Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin

[47] Department of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai

[48] Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an

[49] Department of Radiology, West China Hospital of Sichuan University, Chengdu

[50] Department of Hepatic Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai

来源：

LIVER CANCER | 2023年 / 12卷 / 05期

关键词：

Primary liver cancer; hepatocellular carcinoma; guidelines; China; diagnosis; treatment; UNRESECTABLE HEPATOCELLULAR-CARCINOMA; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; CONTRAST-ENHANCED ULTRASOUND; RANDOMIZED CONTROLLED-TRIAL; STEREOTACTIC BODY RADIOTHERAPY; PREOPERATIVE TRANSARTERIAL CHEMOEMBOLIZATION; SIROLIMUS-BASED IMMUNOSUPPRESSION; VS. RADIOFREQUENCY ABLATION; SURGICAL RESECTION; OPEN-LABEL;

D O I：

10.1159/000530495

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Primary liver cancer, around 75%-85% are hepatocellular carcinoma in China, is the fourth most common malignancy and the second leading cause of tumor-related death, thereby posing a significant threat to the life and health of the Chinese people.Summary: Since the publication of Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China in June 2017, which were updated by the National Health Commission in December 2019, additional high-quality evidence has emerged from researchers worldwide regarding the diagnosis, staging, and treatment of liver cancer, that requires the guidelines to be updated again. The new edition (2022 Edition) was written by more than 100 experts in the field of liver cancer in China, which not only reflects the real-world situation in China, but also may re-shape the nationwide diagnosis and treatment of liver cancer. Key Messages: The new guideline aims to encourage the implementation of evidence-based practice, and improve the national average five-year survival rate for patients with liver cancer, as proposed in the "Health China 2030 Blueprint."

引用

页码：405 / 444

页数：40

共 50 条

[21] The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition
Sakai, Takehiko
Kutomi, Goro
Shien, Tadahiko
Asaga, Sota
Aruga, Tomoyuki
Ishitobi, Makoto
Kuba, Sayaka
Sawaki, Masataka
Terata, Kaori
Tomita, Koichi
Yamauchi, Chikako
Yamamoto, Yutaka
Iwata, Hiroji
Saji, Shigehira
BREAST CANCER, 2024, 31 (01) : 1 - 7
[22] AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022
Thill, Marc
Lueftner, Diana
Kolberg-Liedtke, Cornelia
Albert, Ute-Susann
Banys-Paluchowski, Maggie
Bauerfeind, Ingo
Blohmer, Jens-Uwe
Budach, Wilfried
Dall, Peter
Fallenberg, Eva Maria
Fasching, Peter A.
Fehm, Tanja
Friedrich, Michael
Gerber, Bernd
Gluz, Oleg
Harbeck, Nadia
Heil, Joerg
Huober, Jens
Jackisch, Christian
Kreipe, Hans-Heinrich
Krug, David
Kuehn, Thorsten
Kuemmel, Sherko
Loibl, Sibylle
Lux, Michael
Maass, Nicolai
Mundhenke, Christoph
Nitz, Ulrike
Park-Simon, Tjoung-Won
Reimer, Toralf
Rhiem, Kerstin
Rody, Achim
Schmidt, Marcus
Schneeweiss, Andreas
Schuetz, Florian
Sinn, Hans-Peter
Solbach, Christine
Solomayer, Erich-Franz
Stickeler, Elmar
Thomssen, Christoph
Untch, Michael
Witzel, Isabell
Woeckel, Achim
Mueller, Volkmar
Janni, Wolfgang
Ditsch, Nina
BREAST CARE, 2022, 17 (04) : 421 - 429
[23] The Diagnosis and Treatment of Primary Osteoporosis According to Current Guidelines
Baum, E.
Peters, K. M.
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2008, 105 (33): : 573 - U27
[24] Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma
Kubo, Shoji
Shinkawa, Hiroji
Asaoka, Yoshinari
Ioka, Tatsuya
Igaki, Hiroshi
Izumi, Namiki
Itoi, Takao
Unno, Michiaki
Ohtsuka, Masayuki
Okusaka, Takuji
Kadoya, Masumi
Kudo, Masatoshi
Kumada, Takashi
Kokudo, Norihiro
Sakamoto, Michiie
Sakamoto, Yoshihiro
Sakurai, Hideyuki
Takayama, Tadatoshi
Nakashima, Osamu
Nagata, Yasushi
Hatano, Etsuro
Harada, Kenichi
Murakami, Takamichi
Yamamoto, Masakazu
LIVER CANCER, 2022, 11 (04) : 290 - 314
[25] Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)
Duan, Jianchun
Fang, Wenfeng
Xu, Hairong
Wang, Jinliang
Chen, Yuan
Ding, Yi
Dong, Xiaorong
Fan, Yun
Gao, Beili
Hu, Jie
Huang, Yan
Huang, Cheng
Huang, Dingzhi
Liang, Wenhua
Lin, Lizhu
Liu, Hui
Ma, Zhiyong
Shi, Meiqi
Song, Yong
Tang, Chuanhao
Wang, Jialei
Wang, Lifeng
Wang, Yongfeng
Wang, Zhehai
Yang, Nong
Yao, Yu
Yu, Yan
Yu, Qitao
Zhang, Hongmei
Zhao, Jun
Zhao, Mingfang
Zhu, Zhengfei
Niu, Xiaohui
Zhang, Li
Wang, Jie
JOURNAL OF THE NATIONAL CANCER CENTER, 2023, 3 (04): : 256 - 265
[26] BASL guidelines for the surveillance, diagnosis and treatment of hepatocellular carcinoma
Van Vlierberghe, H
Borbath, I
Delwaide, J
Henrion, J
Michielsen, P
Verslype, C
ACTA GASTRO-ENTEROLOGICA BELGICA, 2004, 67 (01) : 14 - 25
[27] Chemoembolization for Primary and Metastatic Liver Cancer
Liapi, Eleni
Geschwind, Jean-Francois H.
CANCER JOURNAL, 2010, 16 (02) : 156 - 162
[28] Guidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised Edition
Shin, Jeong Eun
Jung, Hye-Kyung
Lee, Tae Hee
Jo, Yunju
Lee, Hyuk
Song, Kyung Ho
Hong, Sung Noh
Lim, Hyun Chul
Lee, Soon Jin
Chung, Soon Sup
Lee, Joon Seong
Rhee, Poong-Lyul
Lee, Kwang Jae
Choi, Suck Chei
Shin, Ein Soon
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 22 (03) : 383 - 411
[29] Surgical treatment of primary liver cancer
吴孟超
陈汉
姚晓平
杨甲梅
杨广顺
沈锋
Journal of Medical Colleges of PLA, 1998, (01) : 1 - 4
[30] The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer
Shiani, Ashok
Narayanan, Shreya
Pena, Luis
Friedman, Mark
CANCER CONTROL, 2017, 24 (03)

← 1 2 3 4 5 →